Abstract GS2-10: Targeting depressive symptoms in younger breast cancer survivors: A randomized controlled trial of mindfulness meditation and survivorship education
P. A. Ganz(UCLA Health), Catherine M. Crespi(University of California, Los Angeles), Laura Petersen(APLA Health), Ann H. Partridge(Dana-Farber Cancer Institute), Laura A. Petersen(Michael E. DeBakey VA Medical Center), Hadine Joffe(Beth Israel Deaconess Medical Center), Elissa Thorner(Johns Hopkins University), Michael R. Irwin(University of California, Los Angeles), Julienne E. Bower(APLA Health), Antonio C. Wolff(Johns Hopkins University)
Cited by 1
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2010|898